Friday, 6 November 2026
M
Meridian Globe
Live briefing
Malaysia's main opposition calls for greater power for states— 日经 Nikkei AsiaJapan logistics startups expand cold food networks in Malaysia, Vietnam— 日经 Nikkei AsiaFast-growing India is the next North America for Japan's Marubeni: CEO— 日经 Nikkei AsiaToyota to bring Celica back to premier rally racing after 32-year break— 日经 Nikkei AsiaU.S. Steel grows to 40% of Nippon Steel profit as prices surge— 日经 Nikkei AsiaThe price of building Japanese stealth frigates in Australia— 日经 Nikkei AsiaMcDonald's wages war on KFC in Japan as consumers crave chicken— 日经 Nikkei AsiaUS midterms live: Nasdaq plunges 5.5% on AI regulation fears— 日经 Nikkei AsiaMalaysia's main opposition calls for greater power for states— 日经 Nikkei AsiaJapan logistics startups expand cold food networks in Malaysia, Vietnam— 日经 Nikkei AsiaFast-growing India is the next North America for Japan's Marubeni: CEO— 日经 Nikkei AsiaToyota to bring Celica back to premier rally racing after 32-year break— 日经 Nikkei AsiaU.S. Steel grows to 40% of Nippon Steel profit as prices surge— 日经 Nikkei AsiaThe price of building Japanese stealth frigates in Australia— 日经 Nikkei AsiaMcDonald's wages war on KFC in Japan as consumers crave chicken— 日经 Nikkei AsiaUS midterms live: Nasdaq plunges 5.5% on AI regulation fears— 日经 Nikkei Asia

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

Source 世界卫生组织 WHO2315d ago
Summary

WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine an…

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-af9f4278

Comments 0 comments

No comments yet. Be the first.

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 · Meridian Globe